3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
5
Neoplasms
4
Breast Neoplasms
4
Esophageal Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Large B-cell Lymphoma
1
Hypoxia
1
Hodgkin Disease
1
Hepatic Malignancies
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
98
Filgrastim
92
Etoposide
92
Dexamethasone
89
Mycophenolic Acid
71
Doxorubicin
70
Whole-Body Irradiation
67
Mercaptopurine
66
Busulfan
65
Tacrolimus
64
Radiotherapy
63
Cyclosporine
62
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled